Omnicell Price To Operating Cash Flows Ratio from 2010 to 2024

OMCL Stock  USD 46.59  1.87  3.86%   
Omnicell Price To Operating Cash Flows Ratio yearly trend continues to be quite stable with very little volatility. Price To Operating Cash Flows Ratio may rise above 10.98 this year. From the period between 2010 and 2024, Omnicell, Price To Operating Cash Flows Ratio regression line of its data series had sample variance of  278.69 and sample variance of  278.69. View All Fundamentals
 
Price To Operating Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
9.39472075
Current Value
10.98
Quarterly Volatility
16.69407493
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omnicell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnicell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.3 M, Interest Expense of 15.5 M or Selling General Administrative of 487.6 M, as well as many indicators such as Price To Sales Ratio of 2.04, Dividend Yield of 0.0 or PTB Ratio of 1.36. Omnicell financial statements analysis is a perfect complement when working with Omnicell Valuation or Volatility modules.
  
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Latest Omnicell's Price To Operating Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Operating Cash Flows Ratio of Omnicell over the last few years. It is Omnicell's Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnicell's overall financial position and show how it may be relating to other accounts over time.
Price To Operating Cash Flows Ratio10 Years Trend
Pretty Stable
   Price To Operating Cash Flows Ratio   
       Timeline  

Omnicell Price To Operating Cash Flows Ratio Regression Statistics

Arithmetic Mean23.48
Coefficient Of Variation71.10
Mean Deviation10.80
Median23.12
Standard Deviation16.69
Sample Variance278.69
Range73.9843
R-Value0.18
Mean Square Error289.96
R-Squared0.03
Significance0.51
Slope0.69
Total Sum of Squares3,902

Omnicell Price To Operating Cash Flows Ratio History

2024 10.98
2023 9.39
2022 28.78
2021 33.84
2020 27.5
2019 23.37
2018 23.12

About Omnicell Financial Statements

Omnicell investors utilize fundamental indicators, such as Price To Operating Cash Flows Ratio, to predict how Omnicell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Operating Cash Flows Ratio 9.39  10.98 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.558
Earnings Share
(0.39)
Revenue Per Share
23.218
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.01)
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.